Piotr Zimniak
Concepts (603)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glutathione Transferase | 62 | 2016 | 174 | 5.650 |
Why?
| Aldehydes | 35 | 2015 | 82 | 3.920 |
Why?
| Longevity | 7 | 2012 | 79 | 1.630 |
Why?
| Lipid Peroxidation | 14 | 2016 | 96 | 1.600 |
Why?
| Isoenzymes | 26 | 2009 | 168 | 1.320 |
Why?
| Caenorhabditis elegans | 6 | 2011 | 135 | 1.190 |
Why?
| Carrier Proteins | 22 | 2004 | 302 | 1.120 |
Why?
| Oxidative Stress | 16 | 2011 | 759 | 1.010 |
Why?
| Glutathione | 33 | 2009 | 296 | 0.970 |
Why?
| Bile Acids and Salts | 20 | 2002 | 76 | 0.940 |
Why?
| Adenosine Triphosphatases | 22 | 2003 | 87 | 0.850 |
Why?
| Caenorhabditis elegans Proteins | 4 | 2011 | 56 | 0.790 |
Why?
| Animals | 85 | 2016 | 13098 | 0.760 |
Why?
| Lithocholic Acid | 12 | 2003 | 20 | 0.740 |
Why?
| ATP-Binding Cassette Transporters | 14 | 2003 | 34 | 0.690 |
Why?
| Adenosine Triphosphate | 19 | 2003 | 231 | 0.630 |
Why?
| GTPase-Activating Proteins | 12 | 2003 | 23 | 0.600 |
Why?
| Receptors, Muscarinic | 5 | 2003 | 19 | 0.590 |
Why?
| Xenobiotics | 6 | 2003 | 28 | 0.580 |
Why?
| Liver | 20 | 2016 | 1105 | 0.580 |
Why?
| Aging | 4 | 2011 | 669 | 0.580 |
Why?
| Signal Transduction | 13 | 2011 | 1608 | 0.460 |
Why?
| Fatty Acids | 3 | 2011 | 143 | 0.440 |
Why?
| Microsomes, Liver | 12 | 1992 | 182 | 0.420 |
Why?
| Mice | 32 | 2016 | 5657 | 0.410 |
Why?
| Geriatrics | 1 | 2012 | 44 | 0.390 |
Why?
| Cloning, Molecular | 7 | 2009 | 189 | 0.370 |
Why?
| Doxorubicin | 12 | 2003 | 233 | 0.370 |
Why?
| Obesity | 2 | 2010 | 1097 | 0.360 |
Why?
| Kinetics | 35 | 2004 | 632 | 0.360 |
Why?
| Cell Membrane | 16 | 2009 | 249 | 0.350 |
Why?
| Substrate Specificity | 22 | 2004 | 192 | 0.330 |
Why?
| Adipose Tissue | 2 | 2008 | 188 | 0.330 |
Why?
| DNA | 4 | 2009 | 543 | 0.330 |
Why?
| Muscarinic Antagonists | 4 | 2003 | 21 | 0.330 |
Why?
| Molecular Sequence Data | 14 | 2009 | 799 | 0.310 |
Why?
| Colonic Neoplasms | 4 | 2005 | 158 | 0.310 |
Why?
| Metabolic Detoxication, Phase I | 1 | 2008 | 11 | 0.310 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 378 | 0.300 |
Why?
| Apoptosis | 11 | 2008 | 1092 | 0.300 |
Why?
| Gene Expression | 4 | 2009 | 612 | 0.300 |
Why?
| Lipid Metabolism | 1 | 2008 | 175 | 0.290 |
Why?
| Rats | 31 | 2005 | 3273 | 0.270 |
Why?
| Catalysis | 12 | 2009 | 89 | 0.270 |
Why?
| Calcium | 8 | 1991 | 401 | 0.270 |
Why?
| Growth Inhibitors | 2 | 2005 | 27 | 0.270 |
Why?
| Chief Cells, Gastric | 2 | 2003 | 2 | 0.260 |
Why?
| Drosophila melanogaster | 2 | 2003 | 31 | 0.260 |
Why?
| Alleles | 9 | 2004 | 252 | 0.260 |
Why?
| Anions | 3 | 1994 | 7 | 0.260 |
Why?
| Receptor, Insulin | 1 | 2005 | 37 | 0.250 |
Why?
| Base Sequence | 9 | 2011 | 657 | 0.250 |
Why?
| Mitogen-Activated Protein Kinases | 8 | 2004 | 154 | 0.250 |
Why?
| Glucuronates | 12 | 1992 | 22 | 0.250 |
Why?
| Transfection | 11 | 2009 | 354 | 0.250 |
Why?
| Liver Diseases, Alcoholic | 2 | 2015 | 34 | 0.250 |
Why?
| Leukemia L5178 | 1 | 2005 | 2 | 0.250 |
Why?
| Citric Acid | 3 | 2010 | 16 | 0.250 |
Why?
| Thymidine Kinase | 1 | 2005 | 19 | 0.250 |
Why?
| Erythrocytes | 5 | 2003 | 83 | 0.240 |
Why?
| Humans | 74 | 2012 | 49877 | 0.240 |
Why?
| Blotting, Western | 15 | 2016 | 587 | 0.240 |
Why?
| Mutagens | 1 | 2005 | 50 | 0.240 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 178 | 0.240 |
Why?
| Biological Transport | 15 | 2003 | 170 | 0.240 |
Why?
| Carcinogens | 7 | 2002 | 197 | 0.230 |
Why?
| Amino Acid Sequence | 12 | 2009 | 579 | 0.230 |
Why?
| Recombinant Proteins | 11 | 2009 | 482 | 0.230 |
Why?
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 5 | 2004 | 10 | 0.230 |
Why?
| RNA Interference | 4 | 2011 | 178 | 0.230 |
Why?
| Models, Molecular | 9 | 2004 | 334 | 0.220 |
Why?
| Phospholipids | 8 | 2001 | 57 | 0.220 |
Why?
| Biological Transport, Active | 15 | 2002 | 32 | 0.220 |
Why?
| Mutagenesis, Site-Directed | 8 | 2004 | 98 | 0.220 |
Why?
| Molecular Mimicry | 1 | 2002 | 38 | 0.210 |
Why?
| Binding Sites | 10 | 2004 | 378 | 0.200 |
Why?
| Membrane Glycoproteins | 5 | 1994 | 244 | 0.200 |
Why?
| Taurine | 3 | 2002 | 14 | 0.200 |
Why?
| Water | 2 | 1999 | 74 | 0.200 |
Why?
| Chromatography, Affinity | 8 | 2009 | 38 | 0.190 |
Why?
| K562 Cells | 9 | 2009 | 41 | 0.180 |
Why?
| Drug Resistance, Neoplasm | 5 | 2003 | 314 | 0.180 |
Why?
| Cell Line | 8 | 2009 | 1010 | 0.170 |
Why?
| Aconitate Hydratase | 2 | 2010 | 9 | 0.170 |
Why?
| Acetyl-CoA Carboxylase | 2 | 2010 | 13 | 0.170 |
Why?
| Carcinoembryonic Antigen | 1 | 1999 | 14 | 0.170 |
Why?
| Valine | 3 | 2000 | 57 | 0.170 |
Why?
| Taurolithocholic Acid | 5 | 2002 | 7 | 0.160 |
Why?
| Azotobacter | 4 | 1983 | 4 | 0.160 |
Why?
| Lipid Peroxides | 4 | 2008 | 10 | 0.160 |
Why?
| Phosphorylation | 7 | 2009 | 526 | 0.160 |
Why?
| Reactive Oxygen Species | 3 | 2011 | 405 | 0.160 |
Why?
| Cysteine Proteinase Inhibitors | 4 | 2009 | 22 | 0.160 |
Why?
| Malonyl Coenzyme A | 2 | 2008 | 7 | 0.160 |
Why?
| CHO Cells | 6 | 2003 | 121 | 0.150 |
Why?
| Cricetinae | 6 | 2003 | 211 | 0.150 |
Why?
| PPAR alpha | 2 | 2016 | 56 | 0.150 |
Why?
| Escherichia coli | 5 | 2009 | 191 | 0.150 |
Why?
| Acetylcholine | 5 | 2003 | 54 | 0.150 |
Why?
| Structure-Activity Relationship | 7 | 2004 | 394 | 0.150 |
Why?
| Isoleucine | 3 | 2004 | 25 | 0.140 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 579 | 0.140 |
Why?
| Proteolipids | 7 | 2003 | 10 | 0.140 |
Why?
| Bile | 4 | 1990 | 23 | 0.140 |
Why?
| Mice, Knockout | 6 | 2016 | 835 | 0.130 |
Why?
| Hyperbilirubinemia, Hereditary | 2 | 1993 | 2 | 0.130 |
Why?
| Hyperbilirubinemia | 2 | 1993 | 9 | 0.130 |
Why?
| Animals, Genetically Modified | 2 | 2005 | 48 | 0.130 |
Why?
| Lung | 3 | 1996 | 501 | 0.130 |
Why?
| Cholestasis | 2 | 1998 | 40 | 0.130 |
Why?
| Mitochondrial Proteins | 1 | 2015 | 88 | 0.120 |
Why?
| Rats, Inbred Strains | 12 | 1992 | 197 | 0.120 |
Why?
| Male | 27 | 2014 | 25427 | 0.120 |
Why?
| Antibiotics, Antineoplastic | 3 | 2003 | 77 | 0.120 |
Why?
| Chrysenes | 3 | 1998 | 3 | 0.120 |
Why?
| Carcinoma, Hepatocellular | 1 | 1997 | 194 | 0.120 |
Why?
| Mutation | 4 | 2009 | 1291 | 0.120 |
Why?
| Protein Processing, Post-Translational | 3 | 2015 | 154 | 0.110 |
Why?
| Genes | 1 | 1994 | 34 | 0.110 |
Why?
| Sodium | 2 | 1993 | 92 | 0.110 |
Why?
| Organic Anion Transporters, Sodium-Dependent | 1 | 1993 | 3 | 0.110 |
Why?
| Hydroxysteroid Dehydrogenases | 1 | 1993 | 4 | 0.110 |
Why?
| Erythrocyte Membrane | 4 | 2001 | 14 | 0.110 |
Why?
| Symporters | 1 | 1993 | 17 | 0.110 |
Why?
| Jaundice, Chronic Idiopathic | 1 | 1993 | 1 | 0.110 |
Why?
| Lung Neoplasms | 4 | 2003 | 601 | 0.110 |
Why?
| RNA, Messenger | 5 | 2014 | 1099 | 0.110 |
Why?
| Crystallography, X-Ray | 5 | 2004 | 148 | 0.110 |
Why?
| Hot Temperature | 3 | 2001 | 204 | 0.110 |
Why?
| Ionophores | 2 | 1991 | 6 | 0.110 |
Why?
| Mice, Inbred C57BL | 2 | 2009 | 1777 | 0.110 |
Why?
| Polymerase Chain Reaction | 2 | 2016 | 456 | 0.110 |
Why?
| Glutathione S-Transferase pi | 7 | 2002 | 24 | 0.110 |
Why?
| Electrophoresis, Polyacrylamide Gel | 6 | 2002 | 102 | 0.110 |
Why?
| Liver Neoplasms | 1 | 1997 | 329 | 0.110 |
Why?
| Steroids | 2 | 2004 | 56 | 0.110 |
Why?
| Sequence Homology, Amino Acid | 4 | 2009 | 145 | 0.100 |
Why?
| Glucagon | 2 | 1983 | 22 | 0.100 |
Why?
| Liposomes | 6 | 2003 | 52 | 0.100 |
Why?
| Oxidation-Reduction | 3 | 2008 | 315 | 0.100 |
Why?
| Internationality | 1 | 2012 | 41 | 0.100 |
Why?
| Carcinogens, Environmental | 2 | 2004 | 22 | 0.100 |
Why?
| Electrophoresis | 2 | 2009 | 16 | 0.100 |
Why?
| Calcium-Binding Proteins | 2 | 1983 | 54 | 0.100 |
Why?
| Epinephrine | 2 | 1983 | 96 | 0.100 |
Why?
| Wound Infection | 1 | 2011 | 27 | 0.100 |
Why?
| Sarcoplasmic Reticulum | 5 | 1991 | 21 | 0.100 |
Why?
| Antineoplastic Agents | 4 | 2003 | 1175 | 0.100 |
Why?
| Peptide Fragments | 6 | 2009 | 207 | 0.100 |
Why?
| Cholic Acids | 2 | 1990 | 2 | 0.100 |
Why?
| Stereoisomerism | 6 | 2004 | 101 | 0.090 |
Why?
| Dinitrochlorobenzene | 3 | 2001 | 5 | 0.090 |
Why?
| Inositol Phosphates | 4 | 2002 | 13 | 0.090 |
Why?
| Radioligand Assay | 4 | 2002 | 46 | 0.090 |
Why?
| Bacterial Infections | 1 | 2011 | 94 | 0.090 |
Why?
| Amiloride | 1 | 1990 | 8 | 0.090 |
Why?
| Bicarbonates | 1 | 1990 | 17 | 0.090 |
Why?
| Lipids | 1 | 2011 | 145 | 0.090 |
Why?
| Phenanthrenes | 2 | 2000 | 12 | 0.090 |
Why?
| Bacterial Proteins | 2 | 2004 | 372 | 0.090 |
Why?
| Anion Transport Proteins | 3 | 1994 | 4 | 0.090 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 1991 | 194 | 0.090 |
Why?
| Tumor Cells, Cultured | 6 | 2003 | 462 | 0.090 |
Why?
| Polycyclic Compounds | 2 | 2001 | 6 | 0.090 |
Why?
| JNK Mitogen-Activated Protein Kinases | 6 | 2007 | 71 | 0.080 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 49 | 0.080 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 197 | 0.080 |
Why?
| Burns | 1 | 2011 | 165 | 0.080 |
Why?
| Mixed Function Oxygenases | 1 | 1989 | 25 | 0.080 |
Why?
| Cell Division | 5 | 2004 | 294 | 0.080 |
Why?
| Disease Models, Animal | 4 | 2016 | 1411 | 0.080 |
Why?
| Glucuronosyltransferase | 6 | 1991 | 122 | 0.080 |
Why?
| Vimentin | 1 | 2009 | 32 | 0.080 |
Why?
| Aldehyde Dehydrogenase | 1 | 2008 | 25 | 0.080 |
Why?
| Amino Acid Substitution | 4 | 2004 | 81 | 0.080 |
Why?
| Receptor, Muscarinic M3 | 3 | 2002 | 7 | 0.080 |
Why?
| Retinal Pigment Epithelium | 1 | 2008 | 11 | 0.080 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 45 | 0.080 |
Why?
| Recombinant Fusion Proteins | 3 | 2005 | 186 | 0.080 |
Why?
| Female | 15 | 2016 | 26555 | 0.080 |
Why?
| Genotype | 1 | 2009 | 539 | 0.080 |
Why?
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2007 | 2 | 0.080 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 39 | 0.080 |
Why?
| Fas Ligand Protein | 1 | 2007 | 17 | 0.080 |
Why?
| Glucose Tolerance Test | 1 | 2008 | 56 | 0.070 |
Why?
| Deoxycholic Acid | 3 | 2002 | 17 | 0.070 |
Why?
| Catalase | 3 | 1976 | 68 | 0.070 |
Why?
| Serotonin | 1 | 2009 | 151 | 0.070 |
Why?
| Homeostasis | 2 | 2008 | 202 | 0.070 |
Why?
| Models, Animal | 2 | 2005 | 227 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 7 | 2007 | 1354 | 0.070 |
Why?
| Enzyme Stability | 2 | 1999 | 20 | 0.070 |
Why?
| Cells, Cultured | 7 | 2009 | 1587 | 0.070 |
Why?
| Gene Library | 2 | 2004 | 42 | 0.070 |
Why?
| Cell Nucleus | 1 | 2007 | 186 | 0.070 |
Why?
| Polymorphism, Genetic | 5 | 2000 | 181 | 0.070 |
Why?
| Saccharomyces cerevisiae | 3 | 1976 | 178 | 0.070 |
Why?
| Cholinergic Agonists | 2 | 2003 | 10 | 0.070 |
Why?
| Cell Line, Transformed | 2 | 2004 | 73 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 7 | 1998 | 326 | 0.070 |
Why?
| Carcinoma, Non-Small-Cell Lung | 3 | 2003 | 154 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2008 | 213 | 0.070 |
Why?
| Antigens, CD | 1 | 2008 | 215 | 0.070 |
Why?
| Molecular Weight | 4 | 1995 | 85 | 0.070 |
Why?
| Protein Kinase C | 3 | 1998 | 70 | 0.070 |
Why?
| Hydroxylation | 4 | 1991 | 61 | 0.070 |
Why?
| Neoplasm Proteins | 2 | 2003 | 321 | 0.070 |
Why?
| Promoter Regions, Genetic | 2 | 2005 | 467 | 0.070 |
Why?
| Genetic Vectors | 2 | 2004 | 128 | 0.070 |
Why?
| Alanine | 3 | 2004 | 41 | 0.070 |
Why?
| Protein Isoforms | 4 | 2015 | 118 | 0.070 |
Why?
| Nuclear Proteins | 1 | 2007 | 242 | 0.070 |
Why?
| Insulin Resistance | 1 | 2008 | 255 | 0.070 |
Why?
| Guinea Pigs | 2 | 2003 | 75 | 0.060 |
Why?
| Carbon Tetrachloride | 1 | 2005 | 22 | 0.060 |
Why?
| Muscle, Skeletal | 1 | 2011 | 769 | 0.060 |
Why?
| Receptors, Steroid | 1 | 2005 | 19 | 0.060 |
Why?
| Transcription Factors | 2 | 2007 | 565 | 0.060 |
Why?
| Epithelium, Corneal | 1 | 2005 | 10 | 0.060 |
Why?
| DNA Primers | 3 | 2011 | 208 | 0.060 |
Why?
| N-Methylscopolamine | 2 | 2002 | 3 | 0.060 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 65 | 0.060 |
Why?
| Multidrug Resistance-Associated Proteins | 3 | 2001 | 16 | 0.060 |
Why?
| Magnetic Resonance Spectroscopy | 8 | 1992 | 245 | 0.060 |
Why?
| Blood Glucose | 1 | 2008 | 432 | 0.060 |
Why?
| Protein Conformation | 3 | 2002 | 165 | 0.060 |
Why?
| Steroid Isomerases | 1 | 2004 | 1 | 0.060 |
Why?
| Hydrogen-Ion Concentration | 4 | 1996 | 168 | 0.060 |
Why?
| Forkhead Transcription Factors | 1 | 2005 | 110 | 0.060 |
Why?
| Models, Biological | 4 | 2008 | 719 | 0.060 |
Why?
| Stress, Psychological | 1 | 2006 | 258 | 0.060 |
Why?
| Peptide Mapping | 5 | 1996 | 22 | 0.060 |
Why?
| Insulin | 2 | 2005 | 453 | 0.060 |
Why?
| DNA, Complementary | 2 | 2002 | 134 | 0.060 |
Why?
| Phosphatidylcholines | 2 | 2001 | 24 | 0.060 |
Why?
| Subcellular Fractions | 2 | 2001 | 34 | 0.060 |
Why?
| Cell Transformation, Neoplastic | 1 | 2005 | 181 | 0.060 |
Why?
| Rats, Mutant Strains | 3 | 1993 | 9 | 0.060 |
Why?
| Oxidants | 2 | 2011 | 54 | 0.060 |
Why?
| Lactones | 1 | 2004 | 25 | 0.060 |
Why?
| Islets of Langerhans | 1 | 2004 | 25 | 0.060 |
Why?
| Microsomes | 2 | 1983 | 35 | 0.060 |
Why?
| Blotting, Southern | 1 | 2004 | 43 | 0.060 |
Why?
| Gene Deletion | 2 | 2015 | 267 | 0.060 |
Why?
| Gene Expression Regulation | 2 | 2006 | 964 | 0.060 |
Why?
| Arteriosclerosis | 1 | 2004 | 54 | 0.060 |
Why?
| Malondialdehyde | 1 | 2004 | 50 | 0.060 |
Why?
| Egtazic Acid | 1 | 2003 | 16 | 0.060 |
Why?
| Vinca Alkaloids | 1 | 2003 | 1 | 0.060 |
Why?
| Calcium-Transporting ATPases | 4 | 1991 | 14 | 0.060 |
Why?
| Hydrogen Peroxide | 2 | 2011 | 114 | 0.060 |
Why?
| Plasmids | 1 | 2004 | 164 | 0.050 |
Why?
| GTP-Binding Proteins | 1 | 2003 | 93 | 0.050 |
Why?
| Epoxy Compounds | 2 | 2000 | 45 | 0.050 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 296 | 0.050 |
Why?
| Tetrazolium Salts | 2 | 2003 | 15 | 0.050 |
Why?
| Multigene Family | 1 | 2003 | 56 | 0.050 |
Why?
| Drosophila Proteins | 1 | 2003 | 26 | 0.050 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 95 | 0.050 |
Why?
| Conserved Sequence | 1 | 2003 | 56 | 0.050 |
Why?
| Thiotepa | 2 | 2000 | 6 | 0.050 |
Why?
| Garlic | 1 | 2002 | 5 | 0.050 |
Why?
| Crystallization | 2 | 1999 | 31 | 0.050 |
Why?
| Allyl Compounds | 1 | 2002 | 11 | 0.050 |
Why?
| Disulfides | 1 | 2002 | 16 | 0.050 |
Why?
| Arginine | 2 | 2001 | 178 | 0.050 |
Why?
| Acetylcholinesterase | 1 | 2002 | 19 | 0.050 |
Why?
| Down-Regulation | 3 | 2011 | 342 | 0.050 |
Why?
| Colchicine | 2 | 2001 | 24 | 0.050 |
Why?
| Thiazoles | 2 | 2003 | 53 | 0.050 |
Why?
| Anticarcinogenic Agents | 1 | 2002 | 32 | 0.050 |
Why?
| Muscle, Smooth | 1 | 2002 | 64 | 0.050 |
Why?
| Phytotherapy | 1 | 2002 | 42 | 0.050 |
Why?
| Antineoplastic Agents, Alkylating | 2 | 2000 | 74 | 0.050 |
Why?
| Binding, Competitive | 3 | 1998 | 94 | 0.050 |
Why?
| Immunoglobulin G | 4 | 2003 | 184 | 0.050 |
Why?
| Phylogeny | 1 | 2003 | 234 | 0.050 |
Why?
| Chromatography, Thin Layer | 5 | 2002 | 25 | 0.050 |
Why?
| Survival Analysis | 1 | 2004 | 670 | 0.050 |
Why?
| Aorta, Thoracic | 1 | 2002 | 94 | 0.050 |
Why?
| Carcinoma, Small Cell | 4 | 2003 | 25 | 0.050 |
Why?
| Protein Binding | 2 | 2001 | 656 | 0.050 |
Why?
| Coronary Artery Disease | 1 | 2005 | 273 | 0.050 |
Why?
| Body Composition | 1 | 2004 | 320 | 0.050 |
Why?
| Bone Density | 1 | 2004 | 384 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2001 | 37 | 0.050 |
Why?
| Quaternary Ammonium Compounds | 1 | 1981 | 29 | 0.050 |
Why?
| Methyltransferases | 1 | 1981 | 29 | 0.050 |
Why?
| Leucine | 2 | 1999 | 115 | 0.050 |
Why?
| Chlorambucil | 1 | 2000 | 4 | 0.050 |
Why?
| Phenotype | 1 | 2004 | 728 | 0.050 |
Why?
| Antiporters | 1 | 1980 | 19 | 0.050 |
Why?
| Cation Transport Proteins | 1 | 1980 | 27 | 0.040 |
Why?
| Hepatocytes | 1 | 2001 | 179 | 0.040 |
Why?
| Antioxidants | 1 | 2002 | 234 | 0.040 |
Why?
| Time Factors | 5 | 2003 | 2890 | 0.040 |
Why?
| Alkanesulfonic Acids | 1 | 1999 | 3 | 0.040 |
Why?
| Enzyme Precursors | 2 | 1976 | 5 | 0.040 |
Why?
| Morpholines | 1 | 1999 | 66 | 0.040 |
Why?
| Tissue Distribution | 2 | 2002 | 163 | 0.040 |
Why?
| Valinomycin | 2 | 1994 | 2 | 0.040 |
Why?
| Membranes, Artificial | 2 | 1994 | 15 | 0.040 |
Why?
| Pancreas | 2 | 2001 | 71 | 0.040 |
Why?
| Formazans | 1 | 1998 | 4 | 0.040 |
Why?
| Metabolism, Inborn Errors | 1 | 1998 | 17 | 0.040 |
Why?
| Oxygen Consumption | 2 | 1976 | 188 | 0.040 |
Why?
| DNA Adducts | 1 | 1999 | 79 | 0.040 |
Why?
| Solvents | 2 | 1997 | 29 | 0.040 |
Why?
| Cholagogues and Choleretics | 1 | 1998 | 6 | 0.040 |
Why?
| Receptors, Cholinergic | 1 | 1998 | 13 | 0.040 |
Why?
| Microvilli | 1 | 1998 | 6 | 0.040 |
Why?
| Oxygen | 1 | 2001 | 321 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1998 | 46 | 0.040 |
Why?
| Glutamic Acid | 1 | 1999 | 108 | 0.040 |
Why?
| Reference Values | 2 | 2004 | 302 | 0.040 |
Why?
| Methionine | 1 | 1999 | 133 | 0.040 |
Why?
| HEPES | 1 | 1997 | 3 | 0.040 |
Why?
| Atropine | 3 | 2003 | 30 | 0.040 |
Why?
| Enzyme Activation | 3 | 2004 | 272 | 0.040 |
Why?
| Static Electricity | 1 | 1997 | 21 | 0.040 |
Why?
| Carbachol | 3 | 2002 | 27 | 0.040 |
Why?
| Benzene Derivatives | 1 | 1997 | 6 | 0.040 |
Why?
| DNA Damage | 1 | 1999 | 298 | 0.040 |
Why?
| T-Lymphocyte Subsets | 1 | 1997 | 38 | 0.040 |
Why?
| Caspase 3 | 2 | 2007 | 93 | 0.040 |
Why?
| Protein Denaturation | 1 | 1996 | 15 | 0.030 |
Why?
| Ethacrynic Acid | 1 | 1996 | 3 | 0.030 |
Why?
| Rats, Inbred F344 | 3 | 1992 | 196 | 0.030 |
Why?
| Diuretics | 1 | 1996 | 28 | 0.030 |
Why?
| Uterus | 1 | 1997 | 87 | 0.030 |
Why?
| Cell Survival | 4 | 2007 | 590 | 0.030 |
Why?
| Adaptation, Physiological | 1 | 1976 | 92 | 0.030 |
Why?
| Protein Carbonylation | 1 | 2015 | 4 | 0.030 |
Why?
| Transcription, Genetic | 2 | 2011 | 370 | 0.030 |
Why?
| Rabbits | 5 | 1991 | 376 | 0.030 |
Why?
| Fluorescent Antibody Technique | 2 | 2009 | 112 | 0.030 |
Why?
| Methylation | 3 | 1992 | 118 | 0.030 |
Why?
| Endothelium, Vascular | 1 | 1996 | 251 | 0.030 |
Why?
| Chemokine CXCL2 | 1 | 2014 | 11 | 0.030 |
Why?
| Microscopy, Fluorescence | 2 | 2007 | 164 | 0.030 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 19 | 0.030 |
Why?
| Vanadates | 1 | 1994 | 8 | 0.030 |
Why?
| Ethylmaleimide | 1 | 1994 | 3 | 0.030 |
Why?
| Eye | 1 | 1995 | 24 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1994 | 31 | 0.030 |
Why?
| Matrix Metalloproteinases | 1 | 2014 | 47 | 0.030 |
Why?
| Diet, High-Fat | 1 | 2016 | 214 | 0.030 |
Why?
| Alanine Transaminase | 1 | 2014 | 117 | 0.030 |
Why?
| Transcriptome | 1 | 2016 | 312 | 0.030 |
Why?
| Actins | 1 | 2014 | 115 | 0.030 |
Why?
| Drug Resistance | 3 | 2003 | 64 | 0.030 |
Why?
| Antibodies | 1 | 2014 | 151 | 0.030 |
Why?
| Genetic Variation | 3 | 2000 | 215 | 0.030 |
Why?
| Daunorubicin | 1 | 1994 | 12 | 0.030 |
Why?
| Membrane Transport Proteins | 3 | 1999 | 47 | 0.030 |
Why?
| Vinblastine | 1 | 1994 | 23 | 0.030 |
Why?
| Fibrosis | 1 | 2014 | 178 | 0.030 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 66 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2014 | 136 | 0.030 |
Why?
| Muscles | 2 | 1992 | 101 | 0.030 |
Why?
| Perfusion | 2 | 1990 | 48 | 0.030 |
Why?
| Bilirubin | 1 | 1993 | 40 | 0.030 |
Why?
| Sheep | 1 | 1993 | 89 | 0.030 |
Why?
| Testis | 2 | 2005 | 65 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 2 | 2003 | 13 | 0.030 |
Why?
| In Situ Nick-End Labeling | 2 | 2004 | 52 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 388 | 0.030 |
Why?
| Rats, Sprague-Dawley | 3 | 2002 | 1578 | 0.030 |
Why?
| Leukotrienes | 1 | 1992 | 9 | 0.030 |
Why?
| Methylamines | 2 | 1983 | 17 | 0.030 |
Why?
| HL-60 Cells | 2 | 2003 | 18 | 0.030 |
Why?
| S-Adenosylmethionine | 2 | 1983 | 62 | 0.030 |
Why?
| Molecular Structure | 3 | 2000 | 293 | 0.020 |
Why?
| Affinity Labels | 1 | 1991 | 5 | 0.020 |
Why?
| Uridine Diphosphate Glucuronic Acid | 1 | 1991 | 9 | 0.020 |
Why?
| Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
| Chemistry, Physical | 1 | 1991 | 6 | 0.020 |
Why?
| Chemical Phenomena | 1 | 1991 | 16 | 0.020 |
Why?
| Solutions | 1 | 1991 | 24 | 0.020 |
Why?
| Cytokines | 1 | 2014 | 607 | 0.020 |
Why?
| Pseudomonas Infections | 1 | 2011 | 47 | 0.020 |
Why?
| Disease Susceptibility | 1 | 2011 | 88 | 0.020 |
Why?
| Androstenedione | 1 | 1991 | 4 | 0.020 |
Why?
| Myocardium | 1 | 1994 | 443 | 0.020 |
Why?
| Clofibrate | 1 | 1991 | 7 | 0.020 |
Why?
| Steroid Hydroxylases | 1 | 1991 | 18 | 0.020 |
Why?
| Bile Ducts | 1 | 1991 | 47 | 0.020 |
Why?
| Molecular Conformation | 2 | 2004 | 66 | 0.020 |
Why?
| Phenobarbital | 1 | 1991 | 17 | 0.020 |
Why?
| Enzyme Induction | 1 | 1991 | 79 | 0.020 |
Why?
| Sulfurtransferases | 1 | 1990 | 3 | 0.020 |
Why?
| Cytosol | 2 | 2007 | 81 | 0.020 |
Why?
| Drug Resistance, Multiple | 2 | 2002 | 24 | 0.020 |
Why?
| Brain | 2 | 2001 | 1310 | 0.020 |
Why?
| Cholic Acid | 1 | 1990 | 1 | 0.020 |
Why?
| Taurocholic Acid | 1 | 1990 | 5 | 0.020 |
Why?
| Sulfotransferases | 1 | 1990 | 39 | 0.020 |
Why?
| Liver Circulation | 1 | 1990 | 21 | 0.020 |
Why?
| Immunohistochemistry | 2 | 2004 | 972 | 0.020 |
Why?
| Drug Interactions | 2 | 2003 | 207 | 0.020 |
Why?
| Azides | 2 | 2001 | 10 | 0.020 |
Why?
| Photoaffinity Labels | 2 | 2001 | 15 | 0.020 |
Why?
| NADPH Dehydrogenase | 1 | 1989 | 9 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2011 | 693 | 0.020 |
Why?
| Biotinylation | 1 | 2009 | 26 | 0.020 |
Why?
| Glutathione Disulfide | 2 | 2000 | 40 | 0.020 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 1989 | 66 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 63 | 0.020 |
Why?
| Cell Line, Tumor | 2 | 2003 | 1388 | 0.020 |
Why?
| Models, Chemical | 2 | 1999 | 64 | 0.020 |
Why?
| Dexamethasone | 1 | 1991 | 424 | 0.020 |
Why?
| Precipitin Tests | 2 | 2002 | 33 | 0.020 |
Why?
| Case-Control Studies | 1 | 2011 | 1129 | 0.020 |
Why?
| Survival Rate | 1 | 2011 | 905 | 0.020 |
Why?
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 1 | 0.020 |
Why?
| Caspase 8 | 1 | 2007 | 10 | 0.020 |
Why?
| Anthracenes | 1 | 2007 | 9 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2008 | 249 | 0.020 |
Why?
| Jurkat Cells | 1 | 2007 | 28 | 0.020 |
Why?
| Organ Specificity | 2 | 2001 | 106 | 0.020 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 1987 | 3 | 0.020 |
Why?
| Co-Repressor Proteins | 1 | 2007 | 18 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2007 | 58 | 0.020 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2007 | 62 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2007 | 63 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2007 | 210 | 0.020 |
Why?
| Protein Transport | 1 | 2007 | 183 | 0.020 |
Why?
| Isoelectric Point | 2 | 1998 | 4 | 0.020 |
Why?
| Cell Transformation, Viral | 1 | 2006 | 25 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2006 | 29 | 0.020 |
Why?
| Blood Platelets | 1 | 2009 | 249 | 0.020 |
Why?
| Lens, Crystalline | 1 | 2006 | 20 | 0.020 |
Why?
| Cell Separation | 2 | 2001 | 89 | 0.020 |
Why?
| Caspases | 1 | 2006 | 104 | 0.020 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 2005 | 8 | 0.020 |
Why?
| Paraquat | 1 | 2005 | 5 | 0.020 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2005 | 19 | 0.020 |
Why?
| Prospective Studies | 1 | 2011 | 2342 | 0.020 |
Why?
| Cytoskeletal Proteins | 1 | 2005 | 49 | 0.020 |
Why?
| NF-E2-Related Factor 2 | 1 | 2005 | 40 | 0.020 |
Why?
| Pregnancy | 3 | 1998 | 2466 | 0.020 |
Why?
| Superoxide Dismutase | 1 | 2005 | 113 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2007 | 424 | 0.020 |
Why?
| Spleen | 1 | 2005 | 170 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2005 | 138 | 0.020 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 35 | 0.010 |
Why?
| Microinjections | 1 | 2004 | 33 | 0.010 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 60 | 0.010 |
Why?
| Cattle | 2 | 1996 | 207 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2005 | 542 | 0.010 |
Why?
| Glutamate-Ammonia Ligase | 1 | 1983 | 9 | 0.010 |
Why?
| Tyrphostins | 1 | 2003 | 8 | 0.010 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 7 | 0.010 |
Why?
| Kidney | 1 | 1988 | 672 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 48 | 0.010 |
Why?
| Calcium Radioisotopes | 1 | 1983 | 7 | 0.010 |
Why?
| Quinazolines | 1 | 2003 | 32 | 0.010 |
Why?
| Flavonoids | 1 | 2003 | 39 | 0.010 |
Why?
| Xanthine Oxidase | 1 | 2003 | 14 | 0.010 |
Why?
| Drug Design | 1 | 2004 | 119 | 0.010 |
Why?
| GTP Phosphohydrolases | 1 | 2003 | 29 | 0.010 |
Why?
| S-Adenosylhomocysteine | 1 | 1983 | 47 | 0.010 |
Why?
| Ultraviolet Rays | 1 | 2003 | 49 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 139 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2003 | 121 | 0.010 |
Why?
| Sex Factors | 1 | 2005 | 691 | 0.010 |
Why?
| Trypsin | 1 | 2003 | 12 | 0.010 |
Why?
| U937 Cells | 1 | 2003 | 14 | 0.010 |
Why?
| Inhibitory Concentration 50 | 1 | 2003 | 71 | 0.010 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 47 | 0.010 |
Why?
| Cross Reactions | 1 | 2003 | 41 | 0.010 |
Why?
| Computational Biology | 1 | 2004 | 214 | 0.010 |
Why?
| Cell Cycle | 1 | 2004 | 226 | 0.010 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2003 | 184 | 0.010 |
Why?
| Intracellular Membranes | 1 | 1983 | 26 | 0.010 |
Why?
| Mice, Inbred A | 1 | 2002 | 15 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 139 | 0.010 |
Why?
| Cholinesterases | 1 | 2002 | 2 | 0.010 |
Why?
| Mass Spectrometry | 3 | 1992 | 284 | 0.010 |
Why?
| Catalytic Domain | 1 | 2002 | 57 | 0.010 |
Why?
| Selenium | 1 | 2002 | 7 | 0.010 |
Why?
| Osmolar Concentration | 2 | 1999 | 63 | 0.010 |
Why?
| Endothelial Cells | 1 | 2004 | 256 | 0.010 |
Why?
| Tritium | 1 | 2002 | 49 | 0.010 |
Why?
| Adenosine Monophosphate | 1 | 2002 | 15 | 0.010 |
Why?
| Glycine | 1 | 2002 | 78 | 0.010 |
Why?
| Filtration | 1 | 2002 | 24 | 0.010 |
Why?
| Hydrolysis | 2 | 1992 | 63 | 0.010 |
Why?
| Intestine, Small | 1 | 2002 | 110 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2004 | 858 | 0.010 |
Why?
| Blotting, Northern | 1 | 2001 | 110 | 0.010 |
Why?
| Heat-Shock Response | 1 | 2001 | 26 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 2001 | 8 | 0.010 |
Why?
| Cations | 1 | 1981 | 10 | 0.010 |
Why?
| Phosphorus Radioisotopes | 1 | 2001 | 8 | 0.010 |
Why?
| Antibody Specificity | 1 | 2001 | 35 | 0.010 |
Why?
| Culture Media | 1 | 2001 | 94 | 0.010 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2003 | 223 | 0.010 |
Why?
| Transcription Factor AP-1 | 1 | 2001 | 62 | 0.010 |
Why?
| DNA Fragmentation | 1 | 2001 | 54 | 0.010 |
Why?
| Haptens | 1 | 2001 | 10 | 0.010 |
Why?
| Sulfuric Acids | 2 | 1991 | 8 | 0.010 |
Why?
| Amino Acid Motifs | 1 | 2001 | 57 | 0.010 |
Why?
| Phenylmethylsulfonyl Fluoride | 1 | 2001 | 1 | 0.010 |
Why?
| ral GTP-Binding Proteins | 1 | 2001 | 3 | 0.010 |
Why?
| Brain Chemistry | 1 | 2001 | 70 | 0.010 |
Why?
| Metals, Rare Earth | 1 | 1980 | 1 | 0.010 |
Why?
| Lanthanum | 1 | 1980 | 4 | 0.010 |
Why?
| Isomerism | 1 | 2000 | 22 | 0.010 |
Why?
| Ruthenium Red | 1 | 1980 | 5 | 0.010 |
Why?
| Alkylating Agents | 1 | 2000 | 23 | 0.010 |
Why?
| Intracellular Fluid | 1 | 2000 | 13 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2005 | 1028 | 0.010 |
Why?
| Acrolein | 1 | 2000 | 3 | 0.010 |
Why?
| Cell Adhesion | 1 | 2000 | 155 | 0.010 |
Why?
| Erythropoiesis | 1 | 1999 | 16 | 0.010 |
Why?
| Macromolecular Substances | 1 | 1999 | 36 | 0.010 |
Why?
| Dimerization | 1 | 1999 | 51 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1999 | 43 | 0.010 |
Why?
| Leukotriene C4 | 1 | 1999 | 1 | 0.010 |
Why?
| Glucosides | 1 | 1979 | 13 | 0.010 |
Why?
| Glycosides | 1 | 1979 | 18 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 457 | 0.010 |
Why?
| Laryngeal Neoplasms | 1 | 1999 | 41 | 0.010 |
Why?
| Baculoviridae | 1 | 1998 | 5 | 0.010 |
Why?
| Parenteral Nutrition, Total | 1 | 1998 | 31 | 0.010 |
Why?
| Flow Cytometry | 1 | 2001 | 470 | 0.010 |
Why?
| False Positive Reactions | 1 | 1998 | 60 | 0.010 |
Why?
| Anilino Naphthalenesulfonates | 1 | 1978 | 5 | 0.010 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 38 | 0.010 |
Why?
| Pepsinogens | 1 | 1998 | 1 | 0.010 |
Why?
| Sincalide | 1 | 1998 | 2 | 0.010 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 3 | 0.010 |
Why?
| Parasympatholytics | 1 | 1998 | 11 | 0.010 |
Why?
| Cholecystokinin | 1 | 1998 | 20 | 0.010 |
Why?
| Air Pollutants | 1 | 1999 | 65 | 0.010 |
Why?
| Fluorescence | 1 | 1978 | 41 | 0.010 |
Why?
| Osmotic Pressure | 1 | 1998 | 11 | 0.010 |
Why?
| Fluoresceins | 1 | 1998 | 15 | 0.010 |
Why?
| Cell Count | 1 | 1998 | 147 | 0.010 |
Why?
| Caco-2 Cells | 1 | 1998 | 26 | 0.010 |
Why?
| Amino Acids | 1 | 2000 | 363 | 0.010 |
Why?
| Spectrometry, Fluorescence | 1 | 1998 | 47 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 1998 | 105 | 0.010 |
Why?
| Benzo(a)pyrene | 1 | 1997 | 12 | 0.010 |
Why?
| Temperature | 1 | 1998 | 163 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1997 | 63 | 0.010 |
Why?
| Cell Differentiation | 1 | 1999 | 649 | 0.010 |
Why?
| Microbodies | 1 | 1976 | 4 | 0.010 |
Why?
| Bone Marrow Cells | 1 | 1997 | 190 | 0.010 |
Why?
| Drug Screening Assays, Antitumor | 1 | 1996 | 131 | 0.010 |
Why?
| Organoids | 1 | 1976 | 36 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 1999 | 508 | 0.010 |
Why?
| Carcinoma, Squamous Cell | 1 | 1999 | 330 | 0.010 |
Why?
| Heme | 1 | 1975 | 21 | 0.010 |
Why?
| Sepsis | 1 | 1998 | 220 | 0.010 |
Why?
| Algorithms | 1 | 1999 | 613 | 0.010 |
Why?
| Consensus Sequence | 1 | 1994 | 24 | 0.010 |
Why?
| Pregnancy Complications | 1 | 1998 | 362 | 0.010 |
Why?
| Adult | 3 | 2001 | 13344 | 0.010 |
Why?
| Sequence Alignment | 1 | 1994 | 121 | 0.010 |
Why?
| Chickens | 1 | 1994 | 108 | 0.010 |
Why?
| Placenta | 1 | 1994 | 129 | 0.010 |
Why?
| Metals | 1 | 1992 | 35 | 0.010 |
Why?
| Esterification | 1 | 1992 | 6 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 1978 | 742 | 0.010 |
Why?
| Acetylation | 1 | 1992 | 92 | 0.010 |
Why?
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 1991 | 1 | 0.010 |
Why?
| Photochemistry | 1 | 1991 | 16 | 0.010 |
Why?
| Ligation | 1 | 1991 | 61 | 0.010 |
Why?
| Infant, Newborn | 1 | 1998 | 2727 | 0.010 |
Why?
| Sulfobromophthalein | 1 | 1989 | 3 | 0.010 |
Why?
| Androstanols | 1 | 1989 | 5 | 0.010 |
Why?
| Neoplasms | 1 | 2000 | 1233 | 0.010 |
Why?
| Calcimycin | 1 | 1989 | 6 | 0.010 |
Why?
| Ionomycin | 1 | 1988 | 4 | 0.000 |
Why?
| Ethers | 1 | 1988 | 8 | 0.000 |
Why?
| Cell Membrane Permeability | 1 | 1988 | 28 | 0.000 |
Why?
| L-Lactate Dehydrogenase | 1 | 1988 | 63 | 0.000 |
Why?
| Ca(2+) Mg(2+)-ATPase | 1 | 1988 | 2 | 0.000 |
Why?
| 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 1 | 1987 | 1 | 0.000 |
Why?
| Swine | 1 | 1988 | 396 | 0.000 |
Why?
| Scintillation Counting | 1 | 1986 | 1 | 0.000 |
Why?
| Spectrum Analysis | 1 | 1986 | 71 | 0.000 |
Why?
| Chromatography, Gas | 1 | 1986 | 14 | 0.000 |
Why?
| Infusions, Intravenous | 1 | 1986 | 211 | 0.000 |
Why?
| Aged | 2 | 1990 | 9450 | 0.000 |
Why?
| Methionine Sulfoximine | 1 | 1983 | 7 | 0.000 |
Why?
| Chloroform | 1 | 1980 | 5 | 0.000 |
Why?
| Methanol | 1 | 1980 | 10 | 0.000 |
Why?
| Chromatography, Gel | 1 | 1980 | 39 | 0.000 |
Why?
| Diacylglycerol Cholinephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| Ethanolaminephosphotransferase | 1 | 1980 | 1 | 0.000 |
Why?
| Centrifugation, Density Gradient | 1 | 1980 | 22 | 0.000 |
Why?
| Muscle Development | 1 | 1980 | 22 | 0.000 |
Why?
| Adolescent | 1 | 1990 | 6402 | 0.000 |
Why?
| Potassium Chloride | 1 | 1979 | 20 | 0.000 |
Why?
| Child, Preschool | 1 | 1987 | 3863 | 0.000 |
Why?
| Child | 1 | 1990 | 6826 | 0.000 |
Why?
| Ultracentrifugation | 1 | 1976 | 9 | 0.000 |
Why?
| Spheroplasts | 1 | 1976 | 4 | 0.000 |
Why?
| Middle Aged | 1 | 1990 | 12289 | 0.000 |
Why?
| Fungal Proteins | 1 | 1976 | 124 | 0.000 |
Why?
|
|
Zimniak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|